Epidermal Growth Factor Receptor-Directed Therapy in Esophageal Cancer

Publisher： Karger

E-ISSN： 1423-0232|73|5-6|281-289

ISSN： 0030-2414

Source： Oncology, Vol.73, Iss.5-6, 2008-05, pp. : 281-289

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Role of the Epidermal Growth Factor Receptor in Breast Cancer

By Chan Samuel   Hill Mark   Gullick William  

Journal of Mammary Gland Biology and Neoplasia, Vol. 11, Iss. 1, 2006-01 ,pp. : 3-11

Springer Publishing Company

Access to resources Recommend Favorite

Human Epidermal Growth Factor Receptor 2 (HER-2/neu)-Directed Therapy for Rare Metastatic Epithelial Tumors with HER-2 Amplification

By  

Case Reports in Oncology, Vol. 9, Iss. 2, 2016-06 ,pp. : 298-304

Karger

Access to resources Recommend Favorite

Impact of clinicopathological characteristics on the efficacy of neoadjuvant therapy in patients with human epidermal growth factor receptor‐2‐positive breast cancer

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 142, Iss. 4, 2018-02 ,pp. : 844-853

John Wiley & Sons Inc

Access to resources Recommend Favorite

Epidermal Growth Factor Receptor Inhibition and Non-Small Cell Lung cancer

By von Eyben Finn  

Critical Reviews in Clinical Laboratory Sciences, Vol. 43, Iss. 4, 2006-08 ,pp. : 291-323

Informa Healthcare

Access to resources Recommend Favorite

Targeting the Epidermal Growth Factor Receptor in Colorectal Cancer: Advances and Controversies

By  

Oncology, Vol. 70, Iss. 3, 2006-07 ,pp. : 161-167

Karger

Access to resources Recommend Favorite